The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for the detection of SARS-CoV and SARS-CoV-2, but does not differentiate between the two viruses.
Publicado el 21 de febrero de 2024 · Inicio del retiro: 3 de enero de 2024
Resumen
FDA registra el retiro Z-1086-2024 de dispositivos médicos de Clase II, publicado el 21 de febrero de 2024 e iniciado el 3 de enero de 2024. Empresa responsable: Quidel Corporation; Estado: En curso; Cantidad reportada: 312 Kits; Lote: UDI-DI: 30014613339229. Lot: 709083. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
One lot of the Sofia 2 Flu + SARS Antigen FIA (Lot 709083) was labelled with incorrect expiration dates. The kits contain pouched cassettes labeled with an expiration date of May 31, 2025, however the correct expiration date for the pouches is September 12, 2024. The kits are labeled with an expiration date of April 30, 2025, however, the correct expiration date for the kits is September 12, 2024. The issue was discovered on November 28, 2023 by a supply chain employee who determined that the kits had expiration dates beyond the FDA authorized shelf life.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Quidel Corporation
- Distribuidor
- US Nationwide distribution in the states of FL, TN, IL, LA, NY, IN.
- Lote
- UDI-DI: 30014613339229. Lot: 709083
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAQuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.20 de mayo de 2026
- FDAQUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 Tests1 de mayo de 2024
- FDAQUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 Tests1 de mayo de 2024
- FDAStryker Neurovascular, Trevo Trak 21 Microcatheter, REF 90338, 0.021in X162cm21 de febrero de 2024
- FDACombiDiagnost R90 1.0 (709030)21 de febrero de 2024
- FDAInflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for9 de agosto de 2017
Preguntas sobre este retiro
¿The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for the detection of SARS-CoV and SARS-CoV-2, but does not differentiate between the two viruses. fue retirado del mercado?
Sí. FDA publicó el retiro Z-1086-2024 el 21 de febrero de 2024. Peligro reportado: One lot of the Sofia 2 Flu + SARS Antigen FIA (Lot 709083) was labelled with incorrect expiration dates. The kits contain pouched cassettes labeled with an expiration date of May 31, 2025, however the correct expiration date for the pouches is September 12, 2024. The kits are labeled with an expiration date of April 30, 2025, however, the correct expiration date for the kits is September 12, 2024. The issue was discovered on November 28, 2023 by a supply chain employee who determined that the kits had expiration dates beyond the FDA authorized shelf life.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter